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ABSTRACT 
        Mycobacterium tuberculosis is a bacterium that causes tuberculosis. Regulation of gene 
expression and mRNA degradation is important for the ability of the bacteria to survive the stressors of 
infection. A multiprotein complex called the degradosome is important for mRNA degradation in better-
studied bacteria such as E. coli, where Ribonuclease E (RNase E) cleaves mRNA into fragments while 
using a scaffold domain to interact with other proteins involved in mRNA degradation. We used M. 
smegmatis, a non-pathogen relative of M. tuberculosis, as a model to define the putative scaffold domains 
of mycobacterial RNase E. Our results suggest that RNase E has two scaffold domains flanking a putative 
catalytic domain 493 amino acids in length. 
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INTRODUCTION 
 Tuberculosis (TB) has become one of the top ten leading causes of death, ranked even higher than 
human immunodeficiency virus (HIV). In 2017, the World Health Organization estimated that 10 million 
people developed TB and 1.6 million died from TB (WHO, 2018). Though antibiotics are effective for 
treating TB, long-term use of antibiotics has caused an evolution of the pathogen, through which many 
strains of TB developed antibiotic resistance. For the treatment of TB, people with active TB that have 
not yet acquired any resistance must be treated with intensive multidrug treatment for at least 6 months 
to eliminate the infection and avoid development of antibiotic resistance in any remaining bacteria (CDC, 
2018). This situation points to an urgent need for new treatments that can cure TB more efficiently 
without creating further drug resistance.  
Mycobacterium tuberculosis is a bacterium that causes tuberculosis. Regulation of gene expression 
and mRNA degradation is important for the ability of the bacteria to survive the stressors of infection. A 
complex known as the degradosome plays an important role in bacterial mRNA degradation. The 
components of the degradosome vary among species, although RNase E, PNPase, and RhlB have 
important roles in the process of mRNA degradation across many species of bacteria (Kovacs et al, 2013). 
However, there are exceptions; in B. subtilis, for example, RNase E is absent and RNase Y associates 
with other proteins to form degradosomes (Lehnik-Habrink et al, 2010). 
RNase E is an abundant and essential endonuclease for many bacteria and was found to be the 
central component in RNA degradosome in E. coli (Mackie, 2013). RNase E has a scaffold domain that 
mediates interactions with other RNA degradation proteins to form the degradosome (Hammarlöf et al, 
2015; Vanzo et al, 1998). In E. coli, RNase E cleaves mRNA into fragments by loading onto a single-
stranded region of the RNA and scanning to find A/U rich regions, where it preferentially cleaves 
(Anderson et al, 2009; Kime et al, 2010). The mRNA fragments will then be cleaved into nucleotides by 
PNPase while the helicase RhlB unwinds any secondary structure (Mohanty et al, 2000; Coburn et al, 
1999). 
Degradosomes may contain additional components. In E. coli, for example, RNase E-scaffolded 
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degradosomes also contain enolase (Miczak, 1996). In addition, E. coli RNase E has a domain called 
segment A that is responsible for membrane binding, and two arginine-rich domains that were suspected 
to be responsible for RNA binding (Murashko et al, 2012; Khemici et al, 2008). In C. crescentus, the 
RNase E scaffold domain contains binding sites for aconitase, RNase D, and PNPase (Voss et al, 2014). 
However, in C. crescentus RhlB was found to bind to the catalytic domain of RNase E (Voss et al, 2014). 
In M. tuberculosis, the major degradosome components were recently reported to be PNPase, RhlE, 
RNase E and RNase J (Płociński et al, 2019). In M. bovis BCG (Bacillus Calmette–Guérin), purified 
RNase E was reported to associate with GroEL, Ppnk, and an acetyltransferase (Kovacs et al, 2005). In 
M. smegmatis, relA, MecA, GroEL, EF-Tu, DIM1, and rplB were identified as associating with RNase 
E (Csanadi et al, 2009). 
The main purpose of this study was to use M. smegmatis, which is a non-pathogenic relative of M. 
tuberculosis, to map the RNase E domain structure to identify scaffold domains and construct a set of 
truncated RNase E strains based on the mapping results. By understanding the domain structure of M. 
smegmatis RNase E and having this set of truncated RNase E strains, it will be possible to identify the 
protein candidates that might interact with RNase E, and map out the region of the non-catalytic domain 
RNase E that each candidate protein interacts with in M. smegmatis.  
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MATERIALS & METHODS 
Q5 (High Fidelity) Polymerase Chain Reaction (PCR) 
 All reactions followed the instruction from New England Biolabs, and the optional 5X Q5 High GC 
Enhancer was added. All PCR using Q5 started with 2 minutes of initial denaturation at 98 °C. After 
initial denaturation, the reaction was repeated for 30 cycles of denaturation for 10 seconds at 98 °C, 
annealing for 30 seconds at the appropriate annealing temperature depending on the primer set that was 
used (see Table 1), and elongation at 72 °C for 30 seconds/kb of the length of the sequence to be amplified. 
The reaction was then incubated for 5 minutes at 72 °C as final elongation step and stored at 4 °C until 
used. All PCR products were mixed with 6X DNA loading dye and loaded into 1% TAE agarose gel from 
Apex to run gel electrophoresis at 140V. The gel with target bands were purified using gel extraction kit 
and instruction from New England Biolabs. 
 
Table 1: Primer sets with description and annealing temperatures that were used for PCR. 
Description Primer Set (𝑭𝒐𝒘𝒂𝒓𝒅	𝑷𝒓𝒊𝒎𝒆𝒓𝑹𝒆𝒗𝒆𝒓𝒔𝒆	𝑷𝒓𝒊𝒎𝒆𝒓) Annealing Temperature 
(°C) 
Amplifying 6X-His-3X-Flag tagged 
rne from pSS267 to make pSS337. 
SSS1237 
CTACAAACTCTTCCTGTCGTCATA
TGAGATCGCCCTGTGGTTCCC 
72 
SSS1238 
TCAGTTAACTACGTCGACATCGAT
ACTAGTCGTGGCTGGGCGGC 
Amplifying the backbone from 
pSS221 to make pSS337. 
SSS1399 TATCGATGTCGACGTAGTTAAC 
61 
SSS1488 ATATGACGACAGGAAGAGTT 
Amplifying tagged rne with a deletion 
of the first 145 amino acids from 
pSS337 for self-assembly to make 
pSS343. 
SSS1562 ACGAGGACTGCGCCGCGGAA 
72 
SSS1563 
GACTGCGCCGCGGAAGCCGCCGC
CGCCCTGGAAGT 
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Table 1 continued 
Description Primer Set (𝑭𝒐𝒘𝒂𝒓𝒅	𝑷𝒓𝒊𝒎𝒆𝒓𝑹𝒆𝒗𝒆𝒓𝒔𝒆	𝑷𝒓𝒊𝒎𝒆𝒓) Annealing Temperature 
(°C) 
Amplifying tagged rne with a deletion 
of the first 308 amino acids from 
pSS337 for self-assembly to make 
pSS370. 
SSS1612 GCCGTCTCGCCTGACGACCC 
72 
SSS1613 
GTCAGGCGAGACGGCGCCGCCG
CCGCCCTGGAAGT 
Amplifying tagged rne with a deletion 
of the first 329 amino acids from 
pSS337 for self-assembly to make 
pSS371. 
SSS1610 GACAAGAGCGACGACTCCGA 
70 
SSS1611 
GTCGTCGCTCTTGTCGCCGCCGC
CGCCCTGGAAGT 
Amplifying tagged rne with deletions 
of the first 145 and last 213 amino 
acids for assembly with pSS221 
backbone to make pSS348. 
SSS1562 ACGAGGACTGCGCCGCGGAA 
72 
SSS1567 CTACGAGTCGGACTTGCGCC 
Amplifying tagged rne with deletions 
of the first 329 and last 213 amino 
acids for assembly with pSS221 
backbone to make pSS380. 
SSS1610B GACAAGAGCGACGACTCCGA 
70 
SSS1567 CTACGAGTCGGACTTGCGCC 
Amplifying tagged rne with deletions 
of the first 308 and last 213 amino 
acids for assembly with pSS221 
backbone to make pSS379. 
SSS1612B GCCGTCTCGCCTGACGACCC 
72 
SSS1567 CTACGAGTCGGACTTGCGCC 
Amplifying the pSS221 backbone for 
insertion tagged rne with deletions of 
the first 308 and last 213 amino acids 
to make pSS379. 
SSS1566 
AAGTCCGACTCGTAGTATCGATGT
CGACGTAGTTA 
72 
SSS1613B 
GTCAGGCGAGACGGCGCCGCCG
CCGCCCTGGAAGT 
 
When standard PCR conditions failed to yield the desired products, touchdown PCR was used. All 
touchdown PCRs using Q5 began with 1 minute of initial denaturation at 98 °C. The reaction cycle of 
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denaturation for 10 seconds at 98 °C, annealing for 30 seconds at 10 °C above the calculated appropriate 
annealing temperature (see Table 2) with 1 °C lowered in each cycle, and elongation at 72 °C for 30 
seconds/kb of the length of sequence amplified, was repeated for 15 cycles. The reaction was then 
repeated for 30 cycles of denaturation for 10 seconds at 98 °C, annealing for 30 seconds at 5 °C below 
the calculated appropriate annealing temperature (see Table 2), and elongation at 72 °C for 30 seconds/kb 
of the length of sequence amplified. The reaction was then incubated for 5 minutes at 72 °C as final 
elongation step and stored at 4 °C until used. Appropriately sized bands were purified by following the 
procedure for using the gel extraction kit from New England Biolabs. 
 
Table 2: Primer sets with descriptions and annealing temperatures that were used for touchdown PCR. 
Description Primer Set (𝑭𝒐𝒘𝒂𝒓𝒅	𝑷𝒓𝒊𝒎𝒆𝒓𝑹𝒆𝒗𝒆𝒓𝒔𝒆	𝑷𝒓𝒊𝒎𝒆𝒓) 
Lowest 
annealing 
temperature 
(°C) 
Amplifying tagged rne with a 
deletion of the last 213 amino 
acids from pSS337 for self-
assembly to make pSS351. 
SSS1566 
AAGTCCGACTCGTAGTATCGATGT
CGACGTAGTTA 
60 
SSS1567 CTACGAGTCGGACTTGCGCC 
Amplifying pSS221 backbone to 
assemble with tagged rne with 
deletions of the first 145 and last 
213 amino acids to make pSS348.  
SSS1566 
AAGTCCGACTCGTAGTATCGATGT
CGACGTAGTTA 
60 
SSS1563 
GACTGCGCCGCGGAAGCCGCCGC
CGCCCTGGAAGT 
Amplifying pSS221 backbone to 
assemble with tagged rne with 
deletions of the first 329 and last 
213 amino acids make pSS380. 
SSS1566 
AAGTCCGACTCGTAGTATCGATGT
CGACGTAGTTA 
72 
SSS1611B 
GTCAGGCGAGACGGCGCCGCCGC
CGCCCTGGAAGT 
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Plasmid constructions through Gibson Assembly 
All reactions used Hi-Fi DNA Assembly Master Mix and followed the procedure from New England 
Biolabs, except that reaction volumes were scaled down to a final volume of 5 µL. The vector mass for 
each reaction was 50 ng and the mass ratio of insert and vector was 1:3. All reactions were incubated at 
50 °C for 1 hour and stored at -20 °C until used. 
 
E. coli transformations 
 DH5-Alpha E. coli cells were thawed on ice and split into tubes with minimum of 20 µL of cells. 2 
µL of Gibson Assembly product was added to the cells and incubated on ice for 30 minutes. The cells 
were then heat shocked for 30 seconds at 42 °C and incubated on ice for 5 minutes. The cells were then 
recovered in 200 µL of SOC medium from New England BioLabs and incubated for 1 hour at 37 °C at 
200 RPM, then plated on LB agar containing appropriate antibiotics. E. coli colonies from plates were 
grown in LB broth, shaking at 200 RPM at 37 °C for 12 to 15 hours. The transformed plasmids (see Table 
3) were harvested using ZR Plasmid Miniprep-Classic kit from Zymo Research using the protocol 
provided, and stored at -20 °C for further use. 
 
Table 3: All plasmids that were used in this report and their E. coli strains 
Plasmid E. coli strain Description Antibiotics 
pSS221 SS-E_0115 Plasmid include 6X-His-3X-Flag tagged rne Nourseothricin 
pSS267 SS-E_0158 
Plasmid contains attP core sequence and 
nourseothricin resistance marker 
Nourseothricin 
pSS337 SS-E_0240 Tagged RNase E with pSS221 backbone. Nourseothricin 
pSS343 SS-E_0254 
First 145 amino acids deleted tagged RNase E 
with pSS221 backbone. 
Nourseothricin 
pSS348 SS-E_0258 
First 145 and last 213 amino acids deleted 
tagged RNase E with pSS221 backbone. 
Nourseothricin 
pSS351 SS-E_0261 
Last 213 amino acids deleted tagged RNase E 
with pSS221 backbone. 
Nourseothricin 
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Table 3 continued 
Plasmid E. coli strain Description Antibiotics 
pSS370 SS-E_0287 
First 308 deleted tagged RNase E with 
pSS221 backbone. 
Nourseothricin 
pSS371 SS-E_0288 
First 329 deleted tagged RNase E with 
pSS221 backbone. 
Nourseothricin 
pSS379 SS-E-0296 
First 308 and last 213 amino acids deleted 
tagged RNase E with pSS221 backbone. 
Nourseothricin 
pSS380 SS-E-0297 
First 329 and last 213 amino acids deleted 
tagged RNase E with pSS221 backbone. 
Nourseothricin 
 
Tagged RNase E integrated in L5 site of M. smegmatis chromosome  
 The M. smegmatis strain used in this project was SS-M_0461. Unlike the wild type of M. smegmatis, 
the original copy of RNase E located at native site was removed and the tagged RNase E was integrated 
into its L5 site of chromosome. To integrate the tagged RNase E into the L5 site of the chromosome, a 
plasmid with a backbone that contain attP core sequence and which includes a start codon, native 
promoter and 5'UTR, and 6xHis-FLAG tagged RNase E was constructed and transformed into wild type 
M. smegmatis. The attP core sequence in the plasmid cooperates with the attB sequence in L5 site of 
chromosome and results in a cross-over which integrates 6xHis-FLAG tagged RNase E in the L5 site.  
For the removal of the original copy of RNase E in the native site, a two-step cross-over was 
performed. A plasmid which includes upstream sequence of RNase E, the last 150 nucleotides of the 
native copy RNase E, and downstream sequence of RNase E was constructed and transformed into M. 
smeg. There are two possiblities for where the first cross-over occurs as the plasmid was transformed- 
one upstream and the other downstream of the full-length RNaseE sequence.  
After the first cross-over occurs, two copies of upstream and downstream sequences are present in 
the chromosome, triggering the second cross-over event. There will also be two possible sites for the 
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second cross-over, one upstream and the other downstream of the RNase E sequence. Two scenarios exist 
for the second cross-over; one is where the native copy of RNase E will remain, and the other is the last 
150 nucleotides of RNase E (from the transformed plasmid) will replace the native copy of RNase E. 
The result of the desired cross-overs is only the last 150 nucleotides of RNase E will exist in the native 
locus, and the strain will be resistant to sucrose and sensitive to hygromycin. 
   
M. smegmatis electrocompetent cell preparation 
 The SS-M_0461 strain of M. smegmatis was grown in DifcoTM Middlebrooks 7H9 broth with 10% 
of 10X ADC, shaking at 200 RPM at 37°C to an OD600 of 0.8 – 1.0. The cells were then collected by 
centrifuging at 3900 RPM for 5 minutes at 4°C and discarding the supernatant. The pelleted cells were 
then washed by gently resuspending in 15 mL of cold 10% glycerol. The cells were collected again by 
repeating centrifugation at 3900 RPM for 5 minutes at 4°C, discarding supernatant, and washing gently 
with 5 mL of cold 10% glycerol. A final collection was completed by centrifuging at 3900 RPM for 5 
minutes at 4°C, discarding the supernatant, and resuspending gently in 1.5 mL of  cold 10% glycerol. 
The competent cells were split into 3 tubes with 500 µL volume each and stored at -80 °C until use in 
electroporation. 
 
M. smegmatis transformation 
 For each transformation, a tube of SS-M_0461 electrocompetent cells were thawed on ice, and 200 
ng of plasmid was added to cells. The cells were transferred to a 0.2 cm electroporation cuvette and the 
cells electroporated with 2.5 kV. The cells were then transferred to a 15 mL conical tube with 2 mL of 
7H9 broth supplemented with 0.2% glycerol, 0.05% Tween, and Albumin Dextrose Catalase (ADC with 
concentration of 5 g/L bovine serum albumin fraction V, 2 g/L 108 dextrose, 0.85 g/L sodium chloride, 
and 3 mg/L catalase) and incubated at 200 RPM at 37°C for 4 hours. After 4 hours of incubation, the 
cells were plated on Middlebrooks 7H10 agar plates + 10% ADC and 0.5% glycerol, and grown for 72 
hours at 37°C. 
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Genomic DNA Extraction 
 For each genomic prep, an overnight culture of M. smegmatis was grown at 200 RPM, 37°C to an 
OD600 of 0.8 – 1.0 and centrifuged at 3,900 RPM for 5 minutes. The supernatant was discarded, washed 
with 200 µL of TE buffer, and transferred to tube pre-filled with 100 µm zirconium beads tube. 400 µL 
of PCI (Phenol /Chloroform /Isoamyl alcohol; 25:24:1, respectively) was added to the tube and vortexed 
for 30 seconds. The tube was then centrifuged at 14,000 RPM for 5 minutes, and the upper aqueous layer 
was collected. 1 mL of ice-cold 95% ethanol was mixed with the aqueous layer and centrifuged at 14,000 
RPM for 5 minutes at 4°C. The supernatant was discarded, the pellet was washed with 1 mL of 70% 
ethanol and centrifuged at 14,000 RPM. After all the supernatant was removed (incubation at room 
temperature for 5 minutes was occasionally necessary to remove excess supernatant), 100 µL of H2O 
was added and the extracted genomic DNA, which was thenstored at room temperature.  
 
M. smegmatis Protein Extraction 
 An overnight culture of M. smegmatis was grown at 200 RPM, 37°C to an OD600 of 0.8 – 1.0. The 
cells were centrifuged at 3,900 RPM for 10 minutes for the 1st wash, and 5 minutes for the 2nd and 3rd 
wash. All washes were performed using 7H9 broth and the supernatant from each wash was discarded. 
The cells were then resuspended in 1 mL of lysate buffer (3.5 mL of lysate buffer was made with 1.75 
mL of 2X buffer G, 87.5 µL of Triton X-100, 0.7 mL of 50% glycerol, 35 µL of PMSF, 35 µL of 10% 
SDS, 350 µL of protease buffer, and 542.5 µL of H2O). The cells were then transferred to a tube and 
lysed using FastPrep-24 5G Homogenizer from MP Biomedicals for 4 cycles (6.5 m/s, 30 seconds per 
cycle). The cells were incubated on ice for 1 minute between each cycle. After 4 cycles the cells were 
centrifuged at 15,000 RPM for 10 minutes at room temperature. The upper aqueous layer was collected 
and stored at -20°C.  
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Bicinchoninic Acid (BCA) Assay  
 BSA standards were set up in a 96 well plate as indicated in Table 4.  
Table 4: Preparation of BSA standards. 
Vial Lysate buffer used in protein extraction (µL) BSA (µL) Concentration (µg/mL) 
A 0 60 (from stock) 2000 
B 30 90 (from stock) 1500 
C 60 60 (from stock) 1000 
D 30 30 (from vial B) 750 
E 60 60 (from vial C) 500 
F 60 60 (from vial E) 250 
G 60 60 (from vial F) 125 
H 48 12 (from vial G) 25 
I 60 0 0 (blank) 
 
 Each standard and protein sample was assayed in duplicate with 25 µL in each well. Each replicate 
was mixed with 200 µL of BCA reagent (ThermoFisher Scientific). After the reagent was added, the plate 
was incubated at 37°C for 30 minutes, and then absorbances at 544 nm were collected. 
 
SDS-PAGE 
A Mini-PROTEAN TGX Stain-Free Gel from BIO-RAD was assembled in the gel cassette and 
filled with running buffer (30.3 g of Tris-Base, 144.1 g of glycine, and 10 g of SDS mixed with 1L of 
H2O) to make sure the gel cassette did not leak. 2 mg of each sample was prepared, mixed with 4X 
loading dye in a total volume of 32 µL, and incubated at 65°C for 20 minutes. 10 µL of protein ladder 
and 32 µL of incubated samples were loaded and ran 140V until the ladder reached the bottom end of 
the gel. 
 
Western Blotting 
 The gel from SDS-PAGE was taken out and agitated in 1X transfer buffer (90 mL of H2O mixed 
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with 10 mL of 10X transfer buffer made by 3.63 g of Tris-Base and 17.28 g of glycine mixed with 240 
mL of 100% methanol and 950 mL) for 20 minutes. A sheet of polyvinylidene difluoride (PVDF) 
membrane was soaked in 100% methanol for 10 minutes and washed with transfer buffer for 5 minutes. 
In addition, two filter paper sheets and two foam pads were soaked in transfer buffer for 20 minutes.  
The gel was assembled in the blotting cassette in the following order- Cassette Top (Black)//Foam 
Pad//Filter Paper//Gel//Membrane//Filter Paper//Foam Pad//Cassette Bottom- and was run at 100V for 
one hour. The membrane was then removed and checked to confirm the ladder was successfully blotted 
to the membrane. The membrane was then agitated in H2O for 5 minutes and then blocking agent (100 
mL 1X Tris-buffered saline (TBS) with 3 g of non-fat milk) for one hour. The membrane was next washed 
in 1X TBS twice, for 5 minutes, and agitated overnight with primary antibody (1:2000 ratio of 
Monoclonal ANTI-FLAG M2 antibody in blocking agent) at 4°C. 
 The primary antibody was then removed, washed with 1X TBS for 5 minutes, and agitated in 
secondary antibody (30 mL of blocking agent with 1 µL of Goat Anti-Mouse HRP antibody) for 30 
minutes at room temperature.  The membrane was washed with 1X TBS with 0.05% Tween 20 for five 
times, 5 minutes each. 2 mL of enhanced chemiluminescence (ECL) substrate was spread on the 
membrane, the membrane was wrapped in plastic wrap, covered to make sure the membrane was not 
exposed to light, and brought to a dark room. The X-ray film was exposed for 2 seconds with the 
membrane and imaged by Azure™ cSeries Advanced Imaging Systems. 
 
Coomassie Blue Staining 
The gel from SDS-PAGE was removed and agitated in H2O for 5 minutes. Next, the gel was agitated 
in staining solution (50% methanol, 10% acetic acid, and 0.25% Coomassie brilliant blue) for 30 minutes. 
The gel was then washed three times with destain solution (50% methanol and 10% acetic acid) for 30 
minutes, and was then agitated overnight in low methanol destain solution (5% methanol and 7.5% acetic 
acid). The stained gel was imaged using Gel Doc™ XR+ Gel Documentation System. 
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RESULTS 
In order to map the M. smegmatis RNase E domain structure and identify potential scaffold 
domains, RNase E amino acid sequences from several species related to M. smegmatis were aligned 
with M. smegmatis RNAse E sequence as the template. 
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Figure 1. Choosing deletion boundaries in M. smegmatis rne. a) Sequence alignment using M. smegmatis RNase E with 
closely-related species (Retrieved from https://www.ebi.ac.uk/Tools/msa/clustalw2/). Each line represents the deletion 
boundary. b) Disorder and binding prediction (based upon amino acid sequence) for M. smegmatis RNase E with schematic 
of deletions. (IUPred2A: https://iupred2a.elte.hu/) Red predicts disorder, where values over 0.5 are predicted to be 
disordered regions. Blue predicts the possible binding proteins binding regions,; values over 0.5 were predicted to be able to 
act as binding domains. 
 
 The alignment shows low similarity exists in the first 145 and beyond 825 amino acids (AAs). 
It can be predicted these two regions might represent binding domains for species-specific partners. 
Amino acid sequence from 331-824 has high similarity, and thus is expected to represent the catalytic 
region. Moderate similarity between 309 and 330 AAs is observed, and thus could represent sequence 
within either the binding or catalytic domains. Deletion boundaries were chosen to account for each of 
these putative domains (i.e., binding, catalytic, and undetermined) (See Fig 1 a).  
 To clarify and support the definition of these deletion regions, disorder and binding prediction 
for M. smegmatis RNase E was performed (See Fig 1b). Typically catalytic domains are highly ordered, 
while binding domains show a lower degree of order. Based on the output, most of the hypothesized 
catalytic domain is predicted to be structured (indicated by a score less than 0.5 in red) rather than in 
binding other proteins (indicated by a score less than 0.5 in blue). All the truncated rne plasmids were 
constructed using PCR and Gibson assembly.  
 All the constructed plasmids were confirmed via PCR and sequenced. In order to construct 
strains which only contained the truncated rne in the genome, the integration of truncated rne plasmid 
and removal of the native copy rne was necessary. Modification of M. smegmatis via integration at the 
L5 site in the chromosome ris reported to a higher efficiency when compared to integration at Giles and 
Tweety (Lee et al, 1991). As a result, it was decided to construct a strain of 6X-His and 3X-Flag tagged 
RNase E (t-rne) integrated at the L5 chromosomal site.  
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Figure 2. Integration of tagged full-length rne into L5 site in M. smegmatis. The attP core sequence within the plasmid is 
a highly similar sequence comparing to the attB core sequence at L5 site in M. smegmatis. The similarity drives the cross-
over event and thereby integrates the plasmid containing tagged full-length RNase E. 
 
To generate the desired strain, a plasmid harboring t-rne, the kanamycin resistance gene, and attP 
core sequence was constructed and transformed via electroporation into wild type M. smegmatis. The 
crossover between the plasmid and the L5 site (see Figure 2) is driven by the similarity between the attP 
core sequence in the plasmid and the attB core sequence in the L5 site (Lee et al, 1991). All the selected 
colonies that were confirmed via PCR to have properly integrated t-rne at L5 were sequenced. 
The next step was to remove the native copy of rne from the above strain with t-rne integrated at 
the L5 site, using the 2-Step strategy. A plasmid (pSS299) with only last 150 nucleotides (nts) of rne 
flanked by 1000nt upstream and 850nt downstream of the native rne sequence was transformed.  The 
plasmid also contains the hygromycin (Hyg) resistance gene and Sac B which makes sucrose toxic to the 
cells. Because pSS 299 has the exact same upstream and downstream regions of native copy rne, two 
cross-over possibilities can occur. In order to integrate the plasmid and replace the native rne gene, one 
cross-over must occur upstream and the other downstream of the 5’ truncated rne sequence.  The first 
and second cross-overs must not happen in the same upstream or downstream region, which essentially 
reverses the integration event; native rne thus remains in the chromosome.  (see Figure 3b).  
Identifying colonies that successfully integrated the truncated, nonfunctional rne and removed the native 
copy was done by screening for rne length and sequence by colony PCR followed by DNA sequencing, 
and Hyg resistance and sucrose sensitivity by plating. The M. smegmatis that was confirmed to have t-
rne at the L5 site and not have the native copy of rne was designated asSS-M_0461. 
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Figure 3. Removing the native copy of rne using 2-step strategy. By transforming plasmid pSS299 which has only the last 
150 nucleotides of native rne and the exact same upstream and downstream sequences, cross-over will occur twice and have 
two different outcomes based on whether the first cross-over occurs within the upstream (a) or downstream (b) regions 
flanking the 150nt rne sequence. The desired result is the last 150nt of rne successfully replaces the native copy of rne, thus 
effectively knocking out the native rne gene. 
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Figure 4. Selection process of modified rne in M. smegmatis after transformation. Upon transformation with the tagged 
deletion versions of rne, two arrangements exist; (1) the truncated rne will replace the full-length version; (2) both full-
length and truncated rne will present in the genome. To identify those only have the truncated rne present in the genome, 
colonies were re-streaked on 7H10 agar plates with either kanamycin or nourseothricin (Nat) . The colonies that only grew 
on Nat where chosen for further study.   
 
Base on the sequence alignments and disorder and binding predictions in Figure 1, all truncated 
rne plasmid constructs were made. Upon transformation into SS-M_0461, colonies with modified rne in 
the L5 site were identified by restreaking from the initial transformation plate onto 7H10 agar plates with 
either kanamycin or nourseothricin (see Figure 4.). If the cells have only the modified rne gene in the L5 
site, they should grow on plates containing nourseothricin, but will not survive on plates containing 
kanamycin. Colonies meeting these criteria were checked with PCR and sequencing to confirm the 
truncated versions were indeed properly integrated.  
In addition, while making the truncated rne strains, some appeared to yield cultures with highly  
aggregated cells. To determine if the aggregation phenotype is dominant, each of the truncated rne 
plasmids were transformed into wild-type M. smegmatis (See Table 5). Deletion of either of the first 145 
or final 213 amino acids either alone or in combination did not yield clumpy strains, and thus were 
omitted from this analysis.   
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Table 5: Cell aggregation check. 
 
  
However, cultures grown from strains in which harbored deletions of first 308 ors, 329 AAs alone 
or in combination with the last 213 AAs appeared to be clumpy. In addition, all yield  clumpy cultures 
when both full-length rne and truncated rne present are in the genome; thus the clumpy phenotype 
appearsto be dominant. The region that might be responsible for cell aggregation might be between 146-
308 AAs, as the strain with the first 145 AAs deleted did not appear clumpy. 
   
 
Figure 5. SDS_PAGE and Western blotting for RNase E variants. (a) Coomassie Blue staining showing protein abundance 
for all samples; 2 mg of total protein was added to each lane. (b) Western blotting using Anti-FLAG primary antibody detecting 
RNase E variants. 
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 Proteins were extracted from each strain cultures and sequence-confirmed truncated rne strain, and 
SDS-PAGE was performed. The sizes of each truncated RNase E version were compared upon Western 
blotting (Fig. 5). By taking the full length as a comparison, it can be seen that the first 308 AAs deletion  
and first 329 AAs deletion, other truncated RNase E had the correct relative sizes which implied that the 
truncated RNase E strains can express properly. 
 For first 308 AAs deletion sample, it appears some degradation occurs as there is a faint band located 
at a position at about 75 KDa. For first 329 AAs deletion sample, though the lower band seems to have 
a similar size with the first 308 AAs deletion, but there is a band that also has similar size with the full 
length RNase E, which implies this strain might contain both versions in the genome. 
 
CONCLUSION & DISCUSSION 
 To map the M. smegmatis RNase E domain structure and identify potential scaffold domains, RNase 
E sequence alignment and disorder prediction results were obtained. The putative region for catalytic 
domain of RNase E in M. smegmatis is 493 amino acids long, from 331-824. In addition, when the 
putative N-terminal scaffold domain of RNase E was truncated beyond the first 308 amino acids, the 
cells appeared to be more aggregated; this aggregation was found to be dominant as the strain appeared 
to be clumpy when both the native and truncated copies of rne were present in the genome.  
Other than the first 329 AAs deletion (∆ 2 - 329 AA) strain, all other truncated rne strains were 
successfully made. In the western blot the strain with the first 308 AAs deleted (∆ 2 - 308 AA) seems to 
have some degradation, though the correct size is also observed in the blot. For the first 329 AAs deletion 
strain (∆ 2 - 329 AA), it appears both full length and truncated tagged rne exists in the genome, as it has 
a band that looks the same as the full length and another band looks similar to the first 308 AAs deletion 
(∆ 2 - 308 AA).  
As a result, it is suggested to double-check the sequence and if necessary, repeat the electroporation 
and integration steps. After having at least one candidate for all the truncated RNase E strains, the future 
experiments will be identifying protein candidates using mass spectrometry, and based on the candidate 
results use biochemical approaches to test putative protein-protein interactions. Another experiment is to 
test that whether truncated RNase E will affect mRNA half-life in M. smegmatis. 
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